0
Skip to Content
NMD Pharma
Home
About
About NMD Pharma
Management team
Our team
Board
Founders
R&D
Pipeline
Science
Neuromuscular diseases
Insights
Scientific publications
News
Press releases
Events
Other news
Investors
Careers
Your career
Find your job
Contact
NMD Pharma
Home
About
About NMD Pharma
Management team
Our team
Board
Founders
R&D
Pipeline
Science
Neuromuscular diseases
Insights
Scientific publications
News
Press releases
Events
Other news
Investors
Careers
Your career
Find your job
Contact
Home
Folder: About
Back
About NMD Pharma
Management team
Our team
Board
Founders
Folder: R&D
Back
Pipeline
Science
Neuromuscular diseases
Insights
Scientific publications
Folder: News
Back
Press releases
Events
Other news
Investors
Folder: Careers
Back
Your career
Find your job
Contact

Insights

Featured
Spinal Muscular Atrophy (SMA) Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with</a> Claus
Aug 15, 2023
Spinal Muscular Atrophy (SMA) Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Claus
Aug 15, 2023
Aug 15, 2023
Spinal Muscular Atrophy (SMA) Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Eden
Aug 8, 2022
Spinal Muscular Atrophy (SMA) Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Eden
Aug 8, 2022
Aug 8, 2022
Myasthenia Gravis Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Ulrik
Jun 21, 2022
Myasthenia Gravis Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Ulrik
Jun 21, 2022
Jun 21, 2022
Myasthenia Gravis Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Sofie
Jun 16, 2022
Myasthenia Gravis Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Sofie
Jun 16, 2022
Jun 16, 2022
Interview with Professor, Dr. Geert Jan Groeneveld about myasthenia gravis
Jun 25, 2021
Interview with Professor, Dr. Geert Jan Groeneveld about myasthenia gravis
Jun 25, 2021
Jun 25, 2021

NMD PHARMA A/S, CVR No. 36899069

Cookie Policy Terms of Use Privacy Policy US Expanded Access Policy

Follow us
LinkedIn and X